2Moyssakis I, Tektonidou MG, Vasilliou VA, et al. Libman-Sacks endocarditis in systemic lupus erythematosus : prevalence, associations, and evolution. Am J Med, 2007, 120: 636-642.
3Edwards CS, Mootoo R, Bhanji A. High grade heart block in association with SLE. Ann Rheum Dis ,2004, 63: 606.
4Costedoat-Chalumeau N,Amoura Z,Villain E,et al. Anti-SSA/Ro antibodies and the heart: more than complete congenital heart block? A review of electrocardiographic and myocardial abnormalities and of treatment options. Arthritis Res Ther, 2005, 7 : 69-73.
5Logar D, Kveder T,Rozman B, et al. Possible association between anti-Ro antibodies and myocarditis or cardiac conduction defects in adults with systemic lupus erythematosus. Ann Rheum Dis, 1990, 49 : 627-629.
6Aravanis C,Toutouzas P, Yatzidis I. Fatal myocardial infarction in lupus erythematosus. Report of a case of a young female patient. Vasc Dis, 1964,1:258-260.
7Westerweel PE, Luyten RK, Koomans HA, et al. Premature atherosclerotic cardiovascular disease in systemic lupus erythematosus. Arthritis Rheum,2007, 56: 1384-1396.
8Bruce IN. 'Not only... but also': factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus. Rheumatology ( Oxford ), 2005, 44 : 1492-1502.
9Rahman P, Gladman DD, Urowitz MB, et al. The cholesterol lowering effect of antimalarial drugs is enhanced in patients with lupus taking corticosteroid drugs. J Rheumatol, 1999, 26: 325 -330.
10Petri M. Review of classification criteria for systemic lupus erythematosus. Rheum Dis Clin North Am,2005, 31: 245-254.
